The tumor weight in YM101-treated group was lower than vehicle (p < 0.01), anti-TGF-β (p < 0.001), and anti-PD-L1 (p = 0.09) with or on the verge of statistical significance (Fig. 6h). This evidence concerns the gene CD274 and neoplasm.